Work

Abstract 1663: Discovery of novel, potent and orally bioavailable SMARCA2 PROTACs with synergistic anti-tumor activity in combination with KRAS G12C inhibitors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1663

Authors: Yonathan Lissanu, Sasi Kotagiri, Nicholas Blazanin, Yawen Wang, Yanyan Han, Xiaobing Liang

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409628299

Cites:

Cited by:

Related to: 10